No-cut CRISPR could be used to treat muscular dystrophy
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
List view / Grid view
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
A study has used new synthetic lipids to deliver CRISPR gene editing tools into cells with up to 90 percent efficiency.
A research team have developed a new CRISPR platform called RESCUE (RNA Editing for Specific C to U Exchange).
Researchers have generated images of CRISPR-Cas9 gene editing for the first time, enabling improvement of the technique.
New method for directed evolution could improve gene therapies and generic drug development.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
A study has reported that genes delivered to rhesus monkeys are still being expressed four years later.
Researchers announce positive pre-clinical results for two sickle cell disease treatment strategies.
Researchers have presented their new technology for accurately inserting genes into the genome without cutting DNA.
The advent of CRISPR/Cas9 gene editing, together with the plummeting cost of whole-genome sequencing, has cleared a path for the development of customised cancer cell models. Here, we discuss recent developments in the field and challenges associated with targeted-therapy resistance.
A study of almost half a million people links a mutation that protects against HIV infection to an earlier death.
The global gene editing tools market is estimated to have accounted for more than US$258 million in terms of value in 2018.
Method IDs which target therapies, inadequately on their own, can be paired up to kill non-responsive cancers...
A new CRISPR-based tool that acts more like a shredder is able to wipe out long stretches of DNA in human cells with programmable targeting...
Gene therapy has been used to restore hearing in an adult mouse model of DFNB9 deafness, one of the most frequent cases of congenital genetic deafness...